# Petmed Express Inc: financial statements, quarterly

PETS · Nasdaq · CIK 1040130 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/pets.md) · [Financials](/companies/pets/financials.md) · [Filings](/companies/pets/filings.md) · [Insiders](/companies/pets/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pets/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [69.5](/filings/0001040130-25-000072.md) | [63.7](/filings/0001040130-25-000072.md) | [65.1 d](/filings/0001040130-26-000019.md) | [66.2](/filings/0001040130-25-000106.md) | [58.0](/filings/0001040130-25-000108.md) | [52.0](/filings/0001040130-26-000007.md) | [50.8 d](/filings/0001040130-26-000019.md) | [51.2](/filings/0001040130-26-000041.md) | [44.4](/filings/0001040130-25-000108.md) | [40.7](/filings/0001040130-26-000007.md) | [42.8 d](/filings/0001040130-26-000019.md) | [41.0](/filings/0001040130-26-000041.md) |
| Cost of revenue | $m | [48.2](/filings/0001040130-25-000072.md) | [44.2](/filings/0001040130-25-000072.md) | [46.0 d](/filings/0001040130-25-000072.md) | [47.2](/filings/0001040130-25-000106.md) | [39.3](/filings/0001040130-25-000108.md) | [35.8](/filings/0001040130-26-000007.md) | [35.6 d](/filings/0001040130-25-000072.md) | [36.8](/filings/0001040130-26-000041.md) | [31.9](/filings/0001040130-25-000108.md) | not reported | not reported | [29.7](/filings/0001040130-26-000041.md) |
| Gross profit | $m | [21.3](/filings/0001040130-25-000072.md) | [19.4](/filings/0001040130-25-000072.md) | [19.1 d](/filings/0001040130-26-000019.md) | [19.0](/filings/0001040130-25-000106.md) | [18.8](/filings/0001040130-25-000108.md) | [16.1](/filings/0001040130-26-000007.md) | [15.2 d](/filings/0001040130-26-000019.md) | [14.4](/filings/0001040130-26-000041.md) | [12.4](/filings/0001040130-25-000108.md) | [9.5](/filings/0001040130-26-000007.md) | [13.9 d](/filings/0001040130-26-000019.md) | [11.3](/filings/0001040130-26-000041.md) |
| Operating income | $m | [0.9](/filings/0001040130-24-000117.md) | [(3.1)](/filings/0001040130-25-000014.md) | [(3.8) d](/filings/0001040130-26-000019.md) | [4.4](/filings/0001040130-25-000106.md) | [0.6](/filings/0001040130-25-000108.md) | [(0.5)](/filings/0001040130-26-000007.md) | [(6.0) d](/filings/0001040130-26-000019.md) | [(34.1)](/filings/0001040130-26-000041.md) | [(8.4)](/filings/0001040130-25-000108.md) | [(10.5)](/filings/0001040130-26-000007.md) | [(5.7) d](/filings/0001040130-26-000019.md) | [(6.2)](/filings/0001040130-26-000041.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | [0.4](/filings/0001040130-26-000007.md) | not reported | [0.5](/filings/0001040130-26-000041.md) | not reported | [0.4](/filings/0001040130-26-000007.md) | not reported | [0.4](/filings/0001040130-26-000041.md) |
| Income tax | $m | [0.6](/filings/0001040130-24-000117.md) | [(0.6)](/filings/0001040130-25-000014.md) | [1.5 d](/filings/0001040130-26-000019.md) | [1.0](/filings/0001040130-25-000106.md) | [(1.4)](/filings/0001040130-25-000108.md) | [0.5](/filings/0001040130-26-000007.md) | [5.7 d](/filings/0001040130-26-000019.md) | [0.0](/filings/0001040130-26-000041.md) | [0.0](/filings/0001040130-25-000108.md) | [0.0](/filings/0001040130-26-000007.md) | [(0.1) d](/filings/0001040130-26-000019.md) | [0.0](/filings/0001040130-26-000041.md) |
| Net income | $m | [0.7](/filings/0001040130-24-000117.md) | [(2.0)](/filings/0001040130-25-000014.md) | [(5.0) d](/filings/0001040130-26-000019.md) | [3.8](/filings/0001040130-25-000106.md) | [2.3](/filings/0001040130-25-000108.md) | [(0.7)](/filings/0001040130-26-000007.md) | [(11.6) d](/filings/0001040130-26-000019.md) | [(34.2)](/filings/0001040130-26-000041.md) | [(8.5)](/filings/0001040130-25-000108.md) | [(10.6)](/filings/0001040130-26-000007.md) | [(4.1) d](/filings/0001040130-26-000019.md) | [(6.1)](/filings/0001040130-26-000041.md) |
| Diluted EPS | $ per share | [0.03](/filings/0001040130-24-000117.md) | [(0.10)](/filings/0001040130-25-000014.md) | not reported | [0.18](/filings/0001040130-25-000106.md) | [0.11](/filings/0001040130-25-000108.md) | [(0.03)](/filings/0001040130-26-000007.md) | not reported | [(1.65)](/filings/0001040130-26-000041.md) | [(0.41)](/filings/0001040130-25-000108.md) | [(0.50)](/filings/0001040130-26-000007.md) | not reported | [(0.28)](/filings/0001040130-26-000041.md) |
| Basic EPS | $ per share | [0.04](/filings/0001040130-24-000117.md) | [(0.10)](/filings/0001040130-25-000014.md) | not reported | [0.18](/filings/0001040130-25-000106.md) | [0.11](/filings/0001040130-25-000108.md) | [(0.03)](/filings/0001040130-26-000007.md) | not reported | [(1.65)](/filings/0001040130-26-000041.md) | [(0.41)](/filings/0001040130-25-000108.md) | [(0.50)](/filings/0001040130-26-000007.md) | not reported | [(0.28)](/filings/0001040130-26-000041.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [53.5](/filings/0001040130-24-000018.md) | [49.4](/filings/0001040130-24-000019.md) | [55.3](/filings/0001040130-25-000072.md) | [46.0](/filings/0001040130-24-000069.md) | [52.0](/filings/0001040130-24-000117.md) | [50.1](/filings/0001040130-25-000014.md) | [54.7](/filings/0001040130-26-000019.md) | [41.1](/filings/0001040130-25-000106.md) | [36.1](/filings/0001040130-25-000108.md) | [26.9](/filings/0001040130-26-000007.md) | [21.4](/filings/0001040130-26-000041.md) | [13.1](/filings/0001040130-26-000041.md) |
| Current assets | $m | [84.6](/filings/0001040130-24-000018.md) | [95.5](/filings/0001040130-24-000019.md) | [93.6](/filings/0001040130-25-000072.md) | [77.6](/filings/0001040130-24-000069.md) | [70.8](/filings/0001040130-24-000117.md) | [68.4](/filings/0001040130-25-000014.md) | [78.9](/filings/0001040130-26-000019.md) | [67.9](/filings/0001040130-25-000106.md) | [59.5](/filings/0001040130-25-000108.md) | [48.5](/filings/0001040130-26-000007.md) | [43.6](/filings/0001040130-26-000041.md) | [27.6](/filings/0001040130-26-000041.md) |
| Total assets | $m | [163](/filings/0001040130-24-000018.md) | [173](/filings/0001040130-24-000019.md) | [170](/filings/0001040130-25-000072.md) | [153](/filings/0001040130-24-000069.md) | [146](/filings/0001040130-24-000117.md) | [145](/filings/0001040130-25-000014.md) | [149](/filings/0001040130-26-000019.md) | [110](/filings/0001040130-25-000106.md) | [100](/filings/0001040130-25-000108.md) | [88.0](/filings/0001040130-26-000007.md) | [81.2](/filings/0001040130-26-000041.md) | [63.8](/filings/0001040130-26-000041.md) |
| Current liabilities | $m | [61.2](/filings/0001040130-24-000018.md) | [72.4](/filings/0001040130-24-000019.md) | [72.2](/filings/0001040130-25-000072.md) | [58.3](/filings/0001040130-24-000069.md) | [48.8](/filings/0001040130-24-000117.md) | [48.0](/filings/0001040130-25-000014.md) | [62.8](/filings/0001040130-26-000019.md) | [57.6](/filings/0001040130-25-000106.md) | [56.7](/filings/0001040130-25-000108.md) | [54.8](/filings/0001040130-26-000007.md) | [52.0](/filings/0001040130-26-000041.md) | [40.6](/filings/0001040130-26-000041.md) |
| Total liabilities | $m | [62.3](/filings/0001040130-24-000018.md) | [73.3](/filings/0001040130-24-000019.md) | [73.2](/filings/0001040130-25-000072.md) | [59.2](/filings/0001040130-24-000069.md) | [49.6](/filings/0001040130-24-000117.md) | [48.6](/filings/0001040130-25-000014.md) | [63.6](/filings/0001040130-26-000019.md) | [58.3](/filings/0001040130-25-000106.md) | [57.2](/filings/0001040130-25-000108.md) | [55.2](/filings/0001040130-26-000007.md) | [52.3](/filings/0001040130-26-000041.md) | [40.8](/filings/0001040130-26-000041.md) |
| Shareholders' equity | $m | [100](/filings/0001040130-24-000018.md) | [100](/filings/0001040130-24-000019.md) | [96.7](/filings/0001040130-26-000019.md) | [93.5](/filings/0001040130-24-000069.md) | [96.4](/filings/0001040130-24-000117.md) | [96.2](/filings/0001040130-25-000014.md) | [85.1](/filings/0001040130-26-000019.md) | [51.5](/filings/0001040130-25-000106.md) | [43.1](/filings/0001040130-25-000108.md) | [32.8](/filings/0001040130-26-000007.md) | [28.9](/filings/0001040130-26-000041.md) | [23.0](/filings/0001040130-26-000041.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(0.8) d](/filings/0001040130-24-000117.md) | [(2.6) d](/filings/0001040130-25-000014.md) | [7.1 d](/filings/0001040130-26-000019.md) | [(8.5)](/filings/0001040130-25-000106.md) | [7.4 d](/filings/0001040130-25-000108.md) | [(1.2) d](/filings/0001040130-26-000007.md) | [7.0 d](/filings/0001040130-26-000019.md) | [(12.3)](/filings/0001040130-26-000041.md) | [(2.2) d](/filings/0001040130-25-000108.md) | [(9.2) d](/filings/0001040130-26-000007.md) | [(4.7) d](/filings/0001040130-26-000019.md) | [(7.7)](/filings/0001040130-26-000041.md) |
| Capital expenditure | $m | [1.0 d](/filings/0001040130-24-000117.md) | [1.1 d](/filings/0001040130-25-000014.md) | [1.3 d](/filings/0001040130-26-000019.md) | [0.7](/filings/0001040130-25-000106.md) | [1.3 d](/filings/0001040130-25-000108.md) | [0.8 d](/filings/0001040130-26-000007.md) | [2.4 d](/filings/0001040130-26-000019.md) | [1.3](/filings/0001040130-26-000041.md) | [2.6 d](/filings/0001040130-25-000108.md) | [(0.0) d](/filings/0001040130-26-000007.md) | [0.7 d](/filings/0001040130-26-000019.md) | [0.6](/filings/0001040130-26-000041.md) |
| Dividends paid | $m | [6.3](/filings/0001040130-26-000019.md) | [0.0 d](/filings/0001040130-25-000014.md) | [0.0 d](/filings/0001040130-26-000019.md) | [0.1](/filings/0001040130-25-000106.md) | [0.1 d](/filings/0001040130-25-000108.md) | [0.0 d](/filings/0001040130-26-000007.md) | [0.0 d](/filings/0001040130-26-000019.md) | [0.0](/filings/0001040130-26-000041.md) | [0.0 d](/filings/0001040130-25-000108.md) | [0.0 d](/filings/0001040130-26-000007.md) | [(0.0) d](/filings/0001040130-26-000019.md) | [0.0](/filings/0001040130-26-000041.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [20.3](/filings/0001040130-24-000018.md) | [20.3](/filings/0001040130-24-000019.md) | [20.3](/filings/0001040130-24-000069.md) | [20.8](/filings/0001040130-24-000117.md) | [20.4](/filings/0001040130-25-000014.md) | [20.9](/filings/0001040130-25-000106.md) | [20.9](/filings/0001040130-25-000108.md) | [20.6](/filings/0001040130-26-000007.md) | [20.8](/filings/0001040130-26-000041.md) | [20.9](/filings/0001040130-25-000108.md) | [21.0](/filings/0001040130-26-000007.md) | [21.7](/filings/0001040130-26-000041.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 21,678,914 at 2026-08-07, from the cover of the [10-Q filed 2026-08-13](/filings/0001040130-26-000041.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.